miércoles, 7 de octubre de 2026
BuscarExplore
es.VIA.NEWS
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· February 23, 2026

Snowflake Cortex Code Expands Towards Supporting Any Data, Anywhere

View original at finance.yahoo.com
Snowflake Cortex Code Expands Towards Supporting Any Data, Anywhere New updates to Cortex Code CLI support popular data systems dbt and Apache Airflow®…
Opening lines of the source · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Developers don't operate in a single system, and AI coding assistants shouldn't either. Modern data work spans multiple systems, teams, and workflows — and the tools we build have to reflect that reality.

    80% confidence

  • Cortex Code is transforming how Braze approaches agentic analytics, with native understanding of datasets, schemas, and columns allowing engineers to spend less time on context and more time getting precise, actionable outputs

    80% confidence

  • Cortex Code has transformed solution development at evolv Consulting by providing a direct, context-aware connection to the Snowflake ecosystem. This translated into over 500 hours in time saving – roughly $100,000 in value – in just the first 20 days of adoption.

    80% confidence

  • More than 12,600 customers around the globe, including hundreds of the world's largest companies, use Snowflake's AI Data Cloud

    80% confidence

  • Snowflake has seen strong adoption of Cortex Code with over 4,400 new users since launch in November 2025

    80% confidence

Data points we hold from this source

Snowflake Inc. · customer count12600 customers

Citado en estos reportajes de Via News

Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Nuestra lectura de los datos ›
Señales que seguimos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patrones que observamos ›
Donde las fuentes discrepan
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,985
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,985 hechos verificados con la fuente5,351 documentos fuente archivados
Consulta estos datos → isubstrate.com
Snowflake Cortex Code Expands Towards Supporting Any Data, Anywhere — Source | Via News | es.VIA.NEWS